Federal Circuit Denies Re-Hearing for Cordis Corporation Patent Claims Against Medtronic, Inc., Abbott Laboratories, Boston Scientific Corporation

Published: Oct 16, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Court of Appeals for the Federal Circuit declines to revisit its decision to uphold a lower court's decision to invalidate patents for drug-eluting coronary stent technology. A federal appeals court last week declined to revisit its decision to uphold the invalidation of patents covering drug-eluting stent technology.

Help employers find you! Check out all the jobs and post your resume.

Back to news